• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Diving Into Every FDA Drug Approval for Cancer Care During May 2025

by MM360 Staff | Jun 5, 2025 | Uncategorized

Source: CureToday articles Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types. Read More

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

by MM360 Staff | Jun 5, 2025 | Myeloma News

Source: Pharmacy Times articles New products are poised to aid pharmacists in proper counting of inventory to prevent medication errors. Read More

Targeted Screening Tools Can Increase Pneumococcal Vaccine Uptake in Health-System Retail Pharmacies

by MM360 Staff | Jun 5, 2025 | Myeloma News

Source: Pharmacy Times articles Implementation of the Plan-Do-Study-Act cycle in health system retail pharmacies significantly increased uptake of 20-valent pneumococcal conjugate vaccine among eligible adults. Read More

Study Finds Vitamin D3 Supplementation Reduces Telomere Attrition

by MM360 Staff | Jun 5, 2025 | Myeloma News

Source: Pharmacy Times articles New research highlights vitamin D’s potential to slow telomere shortening, suggesting it may combat aging and promote cellular health. Read More

Vadadustat and Darbepoetin Alfa Show Similar Safety, Efficacy in Patients With NDD-CKD and DD-CKD

by MM360 Staff | Jun 5, 2025 | Myeloma News

Source: Pharmacy Times articles Vadadustat and darbepoetin alfa show similar safety and efficacy in treating CKD-related anemia, with regional differences impacting cardiovascular risks. Read More
« Older Entries
Next Entries »

Recent Content

  • Utilizing AI in Prostate Cancer Care and Management
  • KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
  • Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
  • Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
  • Op-Ed: Expand Patient Choice to Lower Medication Costs
  • Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer
  • Meta-Analysis Evaluates RSV Viral Load and Symptom Kinetics
  • Personalized Vaccine Elicits Responses in Patients With Kidney Cancer
  • SCIg More Effective Immunoglobulin Option for Immunocompromised Patients With Inborn Errors of Immunity
  • GLP-1 Receptor Agonists Demonstrate Increased Risk of Neovascular Age-Related Macular Degeneration in Diabetes
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT